PR firm in Boston. Editorial placements for biotech founders, medical institutions, and BigLaw.
The PR Summit serves Boston clients across the Kendall Square biotech and life-sciences cluster, the Harvard Medical and Mass General Brigham ecosystem, the route-128 and Cambridge tech founder community, the BigLaw and financial-services market, and the education-adjacent operators that anchor the city's editorial gravity.
Editorial work tuned to biotech, academic medicine, and the Cambridge founder ecosystem.
Boston's editorial readers are dense with scientific literacy. Our work in this market prioritizes the trade and tier-1 outlets that demand it.
Boston is one of the densest biotech and life-sciences markets in the world. Kendall Square anchors a publicly traded biotech ecosystem and an early-stage founder community that reads STAT News, Endpoints, BioPharma Dive, FierceBiotech, and the WSJ and Bloomberg health desks daily. Our Boston engagements treat that audience with the editorial rigor it expects.
Founder PR for Boston biotech and tech includes financing announcements, scientific milestones, partnership coverage, and the late-stage profiles that prepare a public offering or strategic exit. Engagements run the way our digital and print PR practice runs everywhere: we name the publication, name the date, and document the outcome and the timeline in the engagement letter.
Medical practice PR in Boston runs into the academic affiliates (Mass General Brigham, Beth Israel Deaconess, Boston Children’s, Dana-Farber, Brigham and Women’s) and the Harvard Medical School-adjacent specialty practices around the city. Coverage in JAMA-network commentary, the New England Journal-adjacent press, Modern Healthcare, and the WSJ health desk anchors most of the work.
Law firm PR for Boston BigLaw and the boutique firms working life-sciences IP, financial-services litigation, and academic-affiliated technology transfer runs to Massachusetts Bar advertising rules. Trade outlets include The American Lawyer, Law360, Massachusetts Lawyers Weekly, and Boston Business Journal alongside the national tier-1 outlets.
Tech founder work outside biotech, including SaaS, developer tools, climate tech, and consumer software founders working out of Cambridge and Boston proper, draws coverage through TechCrunch, Bloomberg, the WSJ, Boston Business Journal, and the increasingly dense trade press around each vertical.
High-net-worth principals with Boston residency, often emerging from venture, biotech, or financial-services liquidity events, run on a discretion-first engagement model. Disclosure is by authorization only.
Operations are remote with same-business-day reply windows on Eastern Time. In-person briefs are by appointment for principals who request them.
Tell us the publication. We come back with a date documented in the engagement letter.
Thirty-minute editorial brief, no obligation. We tell you which publications are realistic for your story before you commit.